IMAGE: Lung squamous cell carcinoma

Breaking News

Key: Meeting M      Journal J      Funder F

Showing releases 1101-1125 out of 1283.

<< < 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 > >>

Public Release: 25-Feb-2014
The Journal of Neuroscience
Brainstem discovered as important relay site after stroke
After a stroke, sufferers are often faced with the problem of severe movement impairment. Researchers at the Brain Research Institute of the University of Zurich have now discovered that the brainstem could play a major role in the recovery of motor functions. The projection of neurons from this ancient part of the brain into the spinal cord leads to the neural impulses needed for motion being rerouted.

Contact: Dr. Lukas C. Bachmann
bachmann@hifo.uzh.ch
41-446-353-261
University of Zurich

Public Release: 24-Feb-2014
Journal of Clinical Investigation
Blocking autophagy with malaria drug may help overcome resistance to melanoma BRAF drugs
A new preclinical study published online ahead of print in the Journal of Clinical Investigation from Penn Medicine researchers found that the root of BRAF drug resistance may lie in a never-before-seen autophagy mechanism induced by the BRAF inhibitors vermurafenib and dabrafenib.
National Institutes of Health

Contact: Steve Graff
stephen.graff@uphs.upenn.edu
215-349-5653
University of Pennsylvania School of Medicine

Public Release: 24-Feb-2014
Developmental Cell
Like mom or dad? Some cells randomly express one parent's version of a gene over the other
Both of our parents contribute one copy of a gene to our genetic makeup. Generally, both copies are switched on or off together. Occasionally, a cell will begin to use of one copy over the other. Today, a team of researchers at CSHL shows that this random phenomenon is far more likely to be found in mature, developed cell types than in their stem cell precursors, offering an unexpected glimpse of variability in gene expression.
NIH/National Institute of General Medical Sciences, NIH/National Cancer Institute

Contact: Jaclyn Jansen
jjansen@cshl.edu
516-367-8455
Cold Spring Harbor Laboratory

Public Release: 24-Feb-2014
Cancer
Uninsured adolescents and young adults more likely to be diagnosed with advanced cancer
A new American Cancer Society study shows that uninsured adolescents and young adults were far more likely to be diagnosed with late-stage cancer, which is more difficult and expensive to treat and more deadly, compared to young patients with health insurance.
American Cancer Society

Contact: David Sampson
david.sampson@cancer.org
American Cancer Society

Public Release: 24-Feb-2014
Proceedings of the National Academy of Sciences
A paper diagnostic for cancer
A low-cost urine test developed by MIT engineers amplifies signals from growing tumors to detect disease.
National Science Foundation Graduate Research Fellowship, Mazumdar-Shaw International Oncology Fellowship, National Institutes of Health, Burroughs Wellcome Fund, NIH/National Cancer Institute, Howard Hughes Medical Institute

Contact: Sarah McDonnell
s_mcd@mit.edu
617-253-8923
Massachusetts Institute of Technology

Public Release: 24-Feb-2014
Annals of Internal Medicine
Duke teams set treatment priorities in new national research effort
Treatment regimens often evolve without strong scientific evidence of their benefits and drawbacks, particularly in comparison to other drugs or approaches. Now Duke Medicine is participating in a large national initiative aiming to fill in that missing information.
Patient-Centered Outcomes Research Institute

Contact: Rachel Harrison
rachel.harrison@duke.edu
919-419-5069
Duke University Medical Center

Public Release: 24-Feb-2014
Journal of Experimental Medicine
Two-pronged approach successfully targets DNA synthesis in leukemic cells
Researchers show that a novel two-pronged strategy targeting DNA synthesis can treat leukemia in mice while sparing damage to normal blood cells.
NIH/National Cancer Institute, National Institutes of Health

Contact: Rita Sullivan King
news@rupress.org
212-327-8603
Rockefeller University Press

Public Release: 24-Feb-2014
Journal of Clinical Investigation
JCI early table of contents for Feb. 24, 2014
This release contains summaries, links to PDFs, and contact information for the following newsworthy papers to be published online, Feb. 24, 2014: PPAR-γ agonist reverses cigarette smoke induced emphysema in mice; Small molecule-dependent redcution of glutamate improves murine ALS, Increased autophagy associated with BRAF inhibitor resistance; Dynamin 2 as a target for X-linked centronuclear myopathy; Identification of an immune cell trafficking pathway in the CNS, and more.

Contact: Corinne Williams
press_releases@the-jci.org
Journal of Clinical Investigation

Public Release: 24-Feb-2014
Annals of Internal Medicine
Annals of Internal Medicine tip sheet for Feb. 25, 2014
The United States Preventive Services Task Force recommends against the use of beta-carotene or vitamin E supplements for the primary prevention of cardiovascular disease or cancer, according to a recommendation statement being published inAnnals of Internal Medicine.

Contact: Megan Hanks
mhanks@acponline.org
215-351-2656
American College of Physicians

Public Release: 24-Feb-2014
Cancer
Secondary thyroid cancer more deadly than primary malignancy in young individuals
A new analysis has found that adolescents and young adults who develop thyroid cancer as a secondary cancer have a significantly greater risk of dying than those with primary thyroid cancer.

Contact: Evelyn Martinez
sciencenewsroom@wiley.com
201-748-6358
Wiley

Public Release: 24-Feb-2014
Journal of Cell Biology
Mdm2 suppresses tumors by pulling the plug on glycolysis
Cancer cells have long been known to have higher rates of the energy-generating metabolic pathway known as glycolysis. This enhanced glycolysis is thought to allow cancer cells to survive the oxygen-deficient conditions they experience in the center of solid tumors. Researchers reveal how damaged cells normally switch off glycolysis as they shut down and show that defects in this process may contribute to the early stages of tumor development.
Global COE Program, Japan Society for the Promotion of Science, Ministry of Education, Culture, Sports, Science and Technology of Japan, Japan Science and Technology Agency

Contact: Rita Sullivan King
news@rupress.org
212-327-8603
Rockefeller University Press

Public Release: 24-Feb-2014
Journal of Thoracic Oncology
Significant discrepancies between FISH and IHC results for ALK testing
The findings of a recent study indicate that routine testing with both fluorescent in situ hybridization and immunohistochemistry may enhance the detection of ALK-positive non-small cell lung cancer.

Contact: Kristin Richeimer
kristin.richeimer@iaslc.org
720-325-2953
International Association for the Study of Lung Cancer

Public Release: 24-Feb-2014
Journal of Clinical Oncology
Study shows preventive ovarian surgery in BRCA1 mutation carriers should be performed early
The findings of a large international prospective study published in the Journal of Clinical Oncology suggest for the first time that women with BRCA1 mutations should have preventive ovarian surgery (prophylactic oophorectomy) by age 35, as waiting until a later age appears to increase the risk of ovarian cancer before or at the time of the preventive surgery.
Canadian Breast Cancer Research Alliance, National Institutes of Health, Ontario Ministry of Research and Innovation

Contact: Kate Blackburn
kate.blackburn@asco.org
571-483-1379
American Society of Clinical Oncology

Public Release: 24-Feb-2014
Journal of Clinical Investigation
JCI online ahead of print table of contents for Feb. 24, 2014
This release contains summaries, links to PDFs, and contact information for the following newsworthy papers published online, Feb. 24, 2014, in the JCI.

Contact: JCI Media Contact
press_releases@the-jci.org
Journal of Clinical Investigation

Public Release: 24-Feb-2014
Neurosurgical Focus
Tumors 'light up' with new, unique imaging system using scorpion venom protein and a laser
Researchers at Cedars-Sinai have developed a unique, compact, relatively inexpensive imaging device to 'light up' malignant brain tumors and other cancers. The experimental system consists of a special camera designed and developed at Cedars-Sinai and a new, targeted imaging agent based on a synthetic version of a small protein -- a peptide -- found in the venom of the deathstalker scorpion.
Cedars-Sinai Department of Neurosurgery

Contact: Sandy Van
sandy@prpacific.com
808-526-1708
Cedars-Sinai Medical Center

Public Release: 24-Feb-2014
Nature Cell Biology
Building a better mouse model to understand pancreatic cancer
In a new study, researchers report two breakthroughs in understanding pancreatic cancer: the development of the first mouse model that simulates a precursor lesion called intraductal papillary mucinous neoplasia (IPMN), and the identification of an enzyme, Brg1, that appears to help cause the formation of IPMN lesions while also suppressing another precursor lesion.

Contact: Phil Sahm
phil.sahm@hsc.utah.edu
801-581-2517
University of Utah Health Sciences

Public Release: 24-Feb-2014
Journal of Thoracic Oncology
Novel assay developed for detecting ALK rearrangement in NSCLC
Researchers have developed a novel technique for detecting ALK rearrangements in non-small cell lung cancers (NSCLCs) that is more sensitive and easier to perform than currently available techniques. The technique can help enhance the routine practice of diagnostic ALK testing on NSCLCs, which is crucial for identifying patients with advanced NSCLC who are most likely to benefit from targeted therapy with an ALK inhibitor.

Contact: Kristin Richeimer
kristin.richeimer@iaslc.org
720-325-2953
International Association for the Study of Lung Cancer

Public Release: 24-Feb-2014
Preventive oophorectomy reduces risk of death by 77 percent for women with BRCA mutation
Women who carry a BRCA gene mutation and opt for a preventive oophorectomy, or ovary removal surgery, have a 77 percent lower risk of death than those who do not, according to a new study led by Women's College Hospital's Amy Finch and Dr. Steven Narod.

Contact: Julie Saccone
julie.saccone@wchospital.ca
416-323-6400 x4054
Women's College Hospital

Public Release: 24-Feb-2014
Journal of American College of Cardiology
Cardiovascular Institute researcher: Cancer drug may lower sudden cardiac death risk
A researcher at the Cardiovascular Institute at Rhode Island Miriam and Newport hospitals has found that a new class of drugs, originally developed to treat cancer, reduces sudden cardiac death risk after a heart attack. Researchers evaluated mice that had sustained a heart attack and also had abnormal heartbeats and found that inhibition of a protein signal known as c-Src decreased the risk of abnormal heartbeats and sudden cardiac death.
National Institutes of Health, Veterans Admininistration Merit Award, NIH/National Center for Advancing Translation

Contact: Ellen Slingsby
eslingsby@lifespan.org
401-444-6421
Lifespan

Public Release: 24-Feb-2014
Cancer Epidemiology, Biomarkers & Prevention
Cancer patients turning to mass media and non-experts for info
The increasing use of expensive medical imaging procedures in the US like positron emission tomography scans is being driven, in part, by patient decisions made after obtaining information from lay media and non-experts, and not from health care providers.
NIH/National Cancer Institute

Contact: Joseph J. Diorio
jdiorio@asc.upenn.edu
215-746-1798
University of Pennsylvania Annenberg School for Communication

Public Release: 24-Feb-2014
ACS Nano
A fast and effective mechanism to combat an aggressive cancer
Professor Dan Peer of Tel Aviv University has developed a new strategy to tackle an aggressive subtype of ovarian cancer using a new nanoscale drug-delivery system designed to target specific cancer cells. He and his team have devised a cluster of nanoparticles called gagomers, made of fats and coated with a kind of polysugar. When filled with chemotherapy drugs, these clusters accumulate in tumors, producing dramatically therapeutic benefits.

Contact: George Hunka
ghunka@aftau.org
212-742-9070
American Friends of Tel Aviv University

Public Release: 24-Feb-2014
Leukemia
Precursor of multiple myeloma more common in blacks than whites, Mayo study finds
Blacks may be twice as likely as whites to develop multiple myeloma because they are more likely to have a precursor condition known as monoclonal gammopathy of undetermined significance (MGUS), a Mayo Clinic study has found. Not only is MGUS more common in blacks, but the type seen in the black population is also more apt to have features associated with a higher risk of progression to full-blown multiple myeloma, a cancer of a type of white blood cell in bone marrow.
NIH/National Cancer Institute, Jabbs Foundation, Henry J. Predolin Foundation

Contact: Joe Dangor
newsbureau@mayo.edu
507-284-5005
Mayo Clinic

Public Release: 24-Feb-2014
PANCREAS
Personalized medicine best way to treat cancer, study argues
A new study found evidence that assessing the route to cancer on a case-by-case basis might make more sense than basing a patient's cancer treatment on commonly disrupted genes and pathways.
Georgia Tech Foundation, St. Joseph's Mercy Foundation

Contact: Brett Israel
brett.israel@comm.gatech.edu
404-385-1933
Georgia Institute of Technology

Public Release: 23-Feb-2014
Nature Cell Biology
New technology detect cellular memory
In 2009, two women at BRIC, the University of Copenhagen joined forces to develop a new technology that could elucidate the mystery behind cellular memory. With this technology, they have now identified 100 new molecular players that ensure cellular knowledge of own identity at cell division. This is crucial for fetal development, to maintain body functions throughout life and prevent disease. The results are published in Nature Cell Biology.
European Research Council, Danish National Research Foundation, Danish Cancer Society

Contact: Katrine Sonne-Hansen
katrine.sonne@bric.ku.dk
45-35-32-56-48
University of Copenhagen

Public Release: 23-Feb-2014
Kidney International
Researchers make the invisible visible
As the first in the world, researchers from Aarhus have shown that a new scanning technique can see changes in metabolism that have until now remained invisible, while they are taking place.

Contact: Christoffer Laustsen
cl@mr.au.dk
45-78-45-61-06
Aarhus University

Showing releases 1101-1125 out of 1283.

<< < 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 > >>

  Search News Releases

     

 

 

EurekAlert!